UK Superbug Deaths Soar by 17% as Antibiotic Resistance Crisis Deepens
The number of deaths linked to antibiotic-resistant superbugs has skyrocketed by 17% in England last year, according to shocking new figures released by the UK Health Security Agency. The alarming increase, which brings the total number of resistant infections to nearly 400 cases per week, is a stark warning that the ongoing crisis of antimicrobial resistance shows no signs of abating.
The data also reveals a concerning rise in private prescriptions for antibiotics, with 22% dispensed through the private sector in 2024 - a significant jump from previous years. The Pharmacy First scheme, a flagship policy introduced by the government to allow patients to be prescribed antibiotics for common illnesses without seeing a GP, is widely seen as a major contributor to this trend.
Experts warn that the misuse of antibiotics can accelerate the emergence of drug-resistant strains, which are becoming increasingly difficult to treat. "Antibiotic resistance is one of the greatest health threats we face," said Prof Susan Hopkins, chief executive of the UKHSA. "More people than ever are acquiring infections that cannot be effectively treated by antibiotics. This puts them at greater risk of serious illness and even death."
The UKHSA data reveals a concerning rise in cases of bacteraemia - a life-threatening infection where bacteria circulate in the blood - caused by antibiotic-resistant strains, with 20,484 cases reported last year compared to just 18,740 the previous year. This represents a staggering 9.3% increase.
The estimated number of deaths linked to resistant infections has also risen dramatically, from 2,041 in 2023 to 2,379 in 2024 - an additional 338 lives lost to antibiotic-resistant superbugs last year alone.
While some experts welcome the decline in NHS primary care antibiotic use over the past five years, many are sounding the alarm about the risks of the Pharmacy First scheme. "It's positive that we've seen antibiotic use fall in England within the NHS but we need to go further, faster," said Prof Hopkins.
The number of deaths linked to antibiotic-resistant superbugs has skyrocketed by 17% in England last year, according to shocking new figures released by the UK Health Security Agency. The alarming increase, which brings the total number of resistant infections to nearly 400 cases per week, is a stark warning that the ongoing crisis of antimicrobial resistance shows no signs of abating.
The data also reveals a concerning rise in private prescriptions for antibiotics, with 22% dispensed through the private sector in 2024 - a significant jump from previous years. The Pharmacy First scheme, a flagship policy introduced by the government to allow patients to be prescribed antibiotics for common illnesses without seeing a GP, is widely seen as a major contributor to this trend.
Experts warn that the misuse of antibiotics can accelerate the emergence of drug-resistant strains, which are becoming increasingly difficult to treat. "Antibiotic resistance is one of the greatest health threats we face," said Prof Susan Hopkins, chief executive of the UKHSA. "More people than ever are acquiring infections that cannot be effectively treated by antibiotics. This puts them at greater risk of serious illness and even death."
The UKHSA data reveals a concerning rise in cases of bacteraemia - a life-threatening infection where bacteria circulate in the blood - caused by antibiotic-resistant strains, with 20,484 cases reported last year compared to just 18,740 the previous year. This represents a staggering 9.3% increase.
The estimated number of deaths linked to resistant infections has also risen dramatically, from 2,041 in 2023 to 2,379 in 2024 - an additional 338 lives lost to antibiotic-resistant superbugs last year alone.
While some experts welcome the decline in NHS primary care antibiotic use over the past five years, many are sounding the alarm about the risks of the Pharmacy First scheme. "It's positive that we've seen antibiotic use fall in England within the NHS but we need to go further, faster," said Prof Hopkins.